canceldeath
Registry update — unassessed

Resistance Training and Rapamycin to Enhance Bone Formation in Postmenopausal Women

Trial registry update: RECRUITING. No results reported in the supplied registry record.

RCTRoutine significance
Reporter brief

What this changes

The finding has not established an approved change to our evidence assessment.

Source date: Apr 6, 2026 · Discovered: Sep 19, 2026 · Assessed: — · Historical research backfill

What it does not prove

  • This is a protocol description with no outcome data reported, so no claims about efficacy or safety can be made
  • The comparison includes an active intervention (resistance training) combined with drug and placebo, which limits interpretation of which component drives any observed effect
  • Sample size was not reported, preventing assessment of statistical power or whether enrollment was completed

Extracted from supplied source material; model confidence is not a measured probability of correctness.

Design
Rct
Sample size
—
Duration
—
Population
Postmenopausal women aged 60-75 years
Primary outcome
Bone formation and muscle function in elderly postmenopausal women
Effect size
—
Significance
Not reported
Journal
Odense University Hospital
Published
Apr 6, 2026

Recorded source passages

Abstract or registry material supplied for assessment; source version 1. This is not a claim of full-text review.

Participants will be randomized 1:1:1:1 to one of the following treatment regimens: Oral everolimus 5 mg once a week. Oral placebo once a week. Oral everolimus 5 mg once a week plus resistance training RT 1 hour, 3 times weekly. Oral placebo once a week plus resistance training RT 1 hour, 3 times weekly.
The aim of the present clinical trial is to examine the effects of everolimus, resistance training, or their combination on bone and muscle health formation in elderly women aged 60-75 years.

Source versions

Version 1: Superseded

Version 1: Unassessed

Assessment history

One thread per scientific event, no matter how many outlets covered it.

Sign in to join the discussion.

No comments yet

Be the first to weigh in on this evidence.